MicroRNA-302 replacement therapy sensitizes breast cancer cells to ionizing radiation.
MicroRNA-302 replacement therapy sensitizes breast cancer cells to ionizing radiation.
复制标题
DOI:
10.1007/s11095-012-0936-9
复制
发表时间:
2013-04
影响因子:
3.7
通讯作者:
Shim, Hyunsuk
中科院分区:
文献类型:
--
作者:
Liang, Zhongxing;Ahn, Jeffrey;Guo, Donna;Votaw, John R.;Shim, Hyunsuk
Solid tumors can be resistant or develop resistance to radiotherapy. The purpose of this study is to explore whether microRNA-302 is involved in radioresistance and can be exploited as a sensitizer to enhance sensitivity of breast cancer cells to radiation therapy. MiR-302 expression levels in radioresistant cell lines were analyzed in comparison with their parent cell lines. Furthermore, we investigated whether enforced expression of miR-302 sensitized radioresistant breast cancer cells to ionizing radiation in vitro and in vivo. MiR-302 was downregulated in irradiated breast cancer cells. Additionally, the expression levels of miR-302a were inversely correlated with those of AKT1 and RAD52, two critical regulators of radioresistance. More promisingly, miR-302a sensitized radioresistant breast cancer cells to radiation therapy in vitro and in vivo and reduced the expression of AKT1 and RAD52. Our findings demonstrated that decreased expression of miR-302 confers radioresistance and restoration of miR-302 baseline expression sensitizes breast cancer cells to radiotherapy. These data suggest that miR-302 is a potential sensitizer to radiotherapy.
登录
查看更多内容
影响因子:
64.8
作者:
Lu, J;Getz, G;Golub, TR
通讯作者:
Golub, TR
影响因子:
2.8
作者:
Josson, Sajni;Sung, Shian-Ying;Lao, Kaiqin;Chung, Leland W. K.;Johnstone, Peter A. S.
通讯作者:
Johnstone, Peter A. S.
影响因子:
14.9
作者:
Griffiths-Jones S;Grocock RJ;van Dongen S;Bateman A;Enright AJ
通讯作者:
Enright AJ
影响因子:
64.8
作者:
Benson, FE;Baumann, P;West, SC
通讯作者:
West, SC
影响因子:
11.2
作者:
Liang, ZX;Wu, T;Shim, H
通讯作者:
Shim, H